Conceptio › Archive › bioRxiv / medRxiv
bioRxiv / medRxivopen access

Real-world safety profile of Enfortumab Vedotin: A comprehensive pharmacovigilance analysis based on the FDA Adverse Event Reporting System (FAERS)

Xu, Q. et al. · 2026
bioRxiv / medRxiv · Papers · License: Open Access · 2026
Open Source ↗
pharmacology and therapeutics
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗
Record · ID 349783
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.